心脏移植术后肾功能与结局
该研究纳入1988至2010年间接受心脏移植的416例成人患者,术前及每年随访检测实测肾小球滤过率(mGFR)。术前mGFR不能预测死亡或终末期肾病(ESRD);移植后第一年mGFR下降>25%者长期生存显著更差,术后早期需急性肾替代治疗(RRT)者生存受损。作者建议严重肾功能受损患者仍可考虑心脏移植,但需注意选择偏倚。
要点
- 术前mGFR不能预测心脏移植后死亡或ESRD。
- 移植后第一年mGFR下降>25%者长期生存显著更差。
- 术后早期需透析依赖的急性肾功能障碍提示预后不良。
核心结论
- 术前mGFR不能预测心脏移植后死亡或ESRD,但在此选定人群中需同期或后期肾移植。
- 移植后第一年mGFR下降>25%及术后早期透析依赖的急性肾功能障碍者预后不良。
- 作者建议严重肾功能受损患者不论术前肾功能如何仍应考虑心脏移植,但需谨慎解读结果因存在选择偏倚。
研究设计与样本
- 纳入1988至2010年间接受心脏移植的全部成人患者416例。
- 术前及术后每年随访检测mGFR;8例同期接受肾移植,15例因心脏移植后慢性肾衰竭后期接受肾移植。
主要发现
- 心脏移植后第一年mGFR较术前平均下降12%。
- 术前mGFR不能预测死亡或ESRD;年龄较大或使用心室辅助装置(VAD)是术前死亡预测因素。
- 移植后第一年mGFR下降>25%的患者长期生存显著更差。
- 术后需急性RRT与生存受损相关,但在存活者中不预测ESRD。
- 多变量分析中,既往心脏手术、术前VAD和较低mGFR均为RRT的预测因素。
临床怎么用
- 作者建议严重肾功能受损患者不论术前肾功能如何仍应考虑心脏移植。
- 作者鼓励谨慎解读结果,因该人群存在选择偏倚。
局限性
- 作者鼓励谨慎解读结果,因该人群存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether measured glomerular filtration rate (mGFR) is a risk factor for death and/or end-stage renal disease (ESRD) after heart transplantation (HTx). METHODS: All adult patients (n = 416) who underwent HTx between 1988 and 2010 were included. mGFR was performed both preoperatively and postoperatively as annual follow-up. Eight patients received a concomitant kidney transplant (KTx), and 15 underwent late KTx due to chronic renal failure after HTx. RESULTS: The mean drop in mGFR compared with the preoperative value was 12% during the first year after HTx. Preoperative mGFR was not predictive of mortality or ESRD. Older or the use of a ventricular assist device (VAD) were preoperative predictors of death. Long-term survival was significantly worse in the patients who experienced a >25% decrease in mGFR during the first year after transplantation. The need for acute postoperative renal replacement therapy (RRT) was associated with impaired survival but did not predict ESRD among survivors. On multivariable analyses, previous heart surgery, preoperative VAD, and a lower mGFR were all predictors of RRT. In the most recent period, death without previous ESRD was lower, and the only preoperative factors associated with ESRD by multivariable analyses were mechanical ventilation and diabetes mellitus. CONCLUSIONS: Pretransplantation mGFR was not predictive of mortality or ESRD after HTx, but necessitated simultaneous or late-stage KTx in this selected population of patients. However, patients with a decrease in >25% mGFR during the first year post-transplantation, as well as early postoperative dialysis-dependent acute renal dysfunction, had a poor prognosis. We suggest that patients with severely impaired kidney function, irrespective of pretransplantation renal function, still should be considered for HTx, but also encourage careful interpretation of our results given the selection bias involved in this population.
引用
- Kolsrud O, Karason K, Holmberg E, et al. Renal function and outcome after heart transplantation. J Thorac Cardiovasc Surg. 2017. PMID: 29338859. doi:10.1016/j.jtcvs.2017.11.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。